Artal Group S.A. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 10, 2018	SELL	$5.6 - $9.25 $2.24 Million - $3.7 Million	-400,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$6.6 - $7.78 $1.65 Million - $1.95 Million	250,000 Added 166.67%	400,000 $2.84 Million
Q3 2017 Nov 08, 2017	BUY	$5.75 - $7.75 $862,500 - $1.16 Million	150,000	150,000 $1.07 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.79B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.